Patient Characteristics for Large Hemangioblastomas Treated with Radiosurgery, 1993-2023

91 patients with large hemangioblastomas (>2cc) were treated between 1993 and 2023. This multi-center study by Pavel S. Pichardo-Rojas compares von Hippel-Lindau-associated and sporadic cases, analyzing tumor control, survival, and treatment outcomes. Data includes patient age, tumor volume, location, and treatment response metrics.

Use Cases

• Compare patient demographics and tumor characteristics between VHL-associated and sporadic cases based on the description.
• Analyze tumor control rates and survival outcomes (OS/PFS) for large hemangioblastomas.
• Investigate correlations between tumor location (e.g., cerebellar vs. brainstem) and treatment outcomes.
• Study the incidence of radiation necrosis as a treatment complication.
• Model predictors of favorable response to stereotactic radiosurgery for tumors larger than 2cc.

Strengths

• Data covers a 30-year time range (1993-2023) for a rare tumor type.
• Multi-center study with 91 patient records, providing a notable sample size for this condition.
• Includes key comparative metrics like median age (33 vs. 52 years) and tumor volume (3.49cc vs. 6.5cc) for VHL and sporadic groups.
• Outcomes data includes tumor control rate (70%), overall survival (170-199 months), and progression-free survival (108 months).

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Data may reflect temporal and institutional bias inherent to the retrospective, multi-center collection method.

Provenance

Source

figshare, author Pavel S. Pichardo-Rojas.

Collection Method

Retrospective multi-center study.

Time Range

1993 to 2023

Freshness

Last updated 2026-04-17 17:40:16; freshness should be verified.

Geography

null